Measles
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient with clinical suspicion of measles based on the WHO definition of suspected measles case during an outbreak (see definitions below) 2. Presenting at the study sites within 28 days of rash onset 3. Visiting the study sites during the working hours of the study team 4. Written informed consent from participant or, for participants less than 18 years of age, written informed consent from legal guardian and verbal assent if participant is more than 7 years old
Exclusion criteria
Exclusion criteria: 1. Patients with severe conditions requiring immediate referral to an onward facility 2. Refusal to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Result of RDT on capillary blood;Result of ELISA on serum sample;Result of RT-PCR on oral swab sample | — |
Secondary
| Measure | Time frame |
|---|---|
| RDT Result at secondary reading time point -- assuming one or more nurses found the first result to be negative;Usability feedback on ease of test use and implementation -- to be collected from nurse, lab, and general project staff | — |
Countries
Democratic Republic of the Congo
Contacts
Department Director